Day One Biopharmaceuticals
DAWN
DAWN
184 hedge funds and large institutions have $746M invested in Day One Biopharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 69 increasing their positions, 45 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
+20
Holders Change %
+12.2%
% of All Funds
2.5%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
69
Reduced
45
Closed
22
Calls
$1.23M
Puts
$1.76M
Net Calls
-$534K
Net Calls Change
+$741K
Top Buyers
| 1 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
$18.6M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
$32.2M |
| 3 |
VPC
Vestal Point Capital
New York
|
$20.6M |
| 4 |
Millennium Management
New York
|
$10.5M |
| 5 |
Goldman Sachs
New York
|
$12.4M |
